Petar Svorcan

8PUBLICATIONS
16CO-AUTHORS
AutoimmunityImmunogenetics (incl. genetic immunology)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Epidemiological modellingCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 28, 2026
Unlocking the Potential of Population Pharmacokinetic Models of Adalimumab in Patients with Crohn's Disease.

|Jun 09, 2026
Irritable Bowel Syndrome Prevalence in Patients with Inflammatory Bowel Disease in Remission: Single-Center Experience.

|Aug 28, 2025
Real-World Safety of Vedolizumab in Inflammatory Bowel Disease: A Retrospective Cohort Study Supported by FAERS Signal Analysis.

Bojana Milašinović, Sandra Vezmar Kovačević, Srđan Marković

|Aug 28, 2025
Is Deep Remission the Right Time to De-Escalate Biologic Therapy in IBD? A Single-Center Retrospective Study.

Tamara Knezevic Ivanovski, Marija Milic Perovic, Bojan Stopic

|Feb 26, 2025
Telehealth-An Environmentally Friendly Way to Take Care of Patients with Inflammatory Bowel Disease.

Srdjan Marković, Djordje Kralj, Tamara Knežević Ivanovski

|Jan 25, 2025
Review and External Evaluation of Population Pharmacokinetic Models for Vedolizumab in Patients with Inflammatory Bowel Disease: Assessing Predictive Performance and Clinical Applicability.

Marija Jovanović, Ana Homšek, Srđan Marković

Pageof 2

Frequent Collaborators

7 joint publications

Đorđe Kralj

4 joint publications

Katarina Vučićević

3 joint publications

Srdjan Markovic

2 joint publications

Ana Homšek